Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,425 signal articles · 130 in last 24h · 116,182 total before filter · latest 42m ago
130last 24h
1728last 7d
282● bullish (7d)
158● bearish (7d)
205publishers
AllMacro315Earnings794M&A99Regulatory27Product16Analyst24
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Drugmakers Climb On Q2 Reports, Even As One Misses Profit Views
Investor's Business Daily18d agobearish
Drugmakers Climb On Q2 Reports, Even As One Misses Profit Views

Teva Pharmaceutical Industries climbed above an important chart level Wednesday, after the company's bullish guidance overshadowed mixed second-quarter results. Teva earnings thinned to 2 cents a share after subtracting costs from an acquisition. The profit came in below the consensus estimate of 5 cents a share.

Morgan Stanley resets Akamai stock price target amid sell-off
TheStreet18d agobearish
Morgan Stanley resets Akamai stock price target amid sell-off

Wall Street is watching Akamai Technologies closely after a blockbuster deal reshaped the company's growth story earlier this year. Morgan Stanley reaffirmed its “Overweight” rating on Akamai (AKAM) in a July 27 research note shared with me, keeping its price target at $165, roughly 48% above the ...